nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpromazine—BCHE—peripheral nervous system neoplasm	0.333	0.719	CbGaD
Chlorpromazine—ABCB1—peripheral nervous system neoplasm	0.13	0.282	CbGaD
Chlorpromazine—ABCB11—Vincristine—peripheral nervous system neoplasm	0.0453	0.149	CbGbCtD
Chlorpromazine—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0288	0.0946	CbGbCtD
Chlorpromazine—BCHE—Cisplatin—peripheral nervous system neoplasm	0.0285	0.0939	CbGbCtD
Chlorpromazine—ABCB11—Doxorubicin—peripheral nervous system neoplasm	0.0283	0.0932	CbGbCtD
Chlorpromazine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0208	0.0685	CbGbCtD
Chlorpromazine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0182	0.0599	CbGbCtD
Chlorpromazine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0182	0.0599	CbGbCtD
Chlorpromazine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0166	0.0547	CbGbCtD
Chlorpromazine—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0141	0.0463	CbGbCtD
Chlorpromazine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0126	0.0415	CbGbCtD
Chlorpromazine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0109	0.0359	CbGbCtD
Chlorpromazine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0101	0.0333	CbGbCtD
Chlorpromazine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00814	0.0268	CbGbCtD
Chlorpromazine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00777	0.0255	CbGbCtD
Chlorpromazine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00724	0.0238	CbGbCtD
Chlorpromazine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00712	0.0234	CbGbCtD
Chlorpromazine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00485	0.016	CbGbCtD
Chlorpromazine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00465	0.0153	CbGbCtD
Chlorpromazine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00457	0.015	CbGbCtD
Chlorpromazine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00426	0.014	CbGbCtD
Chlorpromazine—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.00411	0.0798	CbGeAlD
Chlorpromazine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00291	0.00957	CbGbCtD
Chlorpromazine—CALM1—trigeminal nerve—peripheral nervous system neoplasm	0.00247	0.0479	CbGeAlD
Chlorpromazine—HTR7—vagus nerve—peripheral nervous system neoplasm	0.00225	0.0438	CbGeAlD
Chlorpromazine—HTR6—ganglion—peripheral nervous system neoplasm	0.00187	0.0363	CbGeAlD
Chlorpromazine—DRD5—ganglion—peripheral nervous system neoplasm	0.00182	0.0353	CbGeAlD
Chlorpromazine—CALM1—cranial nerve—peripheral nervous system neoplasm	0.00176	0.0341	CbGeAlD
Chlorpromazine—CALM2—pons—peripheral nervous system neoplasm	0.00174	0.0339	CbGeAlD
Chlorpromazine—CALM1—pons—peripheral nervous system neoplasm	0.00174	0.0337	CbGeAlD
Chlorpromazine—HTR7—cranial nerve—peripheral nervous system neoplasm	0.00172	0.0333	CbGeAlD
Chlorpromazine—HTR7—pons—peripheral nervous system neoplasm	0.0017	0.0329	CbGeAlD
Chlorpromazine—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.0015	0.0292	CbGeAlD
Chlorpromazine—DRD1—nerve—peripheral nervous system neoplasm	0.00141	0.0273	CbGeAlD
Chlorpromazine—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00141	0.0273	CbGeAlD
Chlorpromazine—DRD1—ganglion—peripheral nervous system neoplasm	0.00139	0.027	CbGeAlD
Chlorpromazine—SLC22A1—ganglion—peripheral nervous system neoplasm	0.0011	0.0214	CbGeAlD
Chlorpromazine—HTR2C—ganglion—peripheral nervous system neoplasm	0.00108	0.021	CbGeAlD
Chlorpromazine—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00107	0.0208	CbGeAlD
Chlorpromazine—HTR2A—pons—peripheral nervous system neoplasm	0.00106	0.0205	CbGeAlD
Chlorpromazine—HTR1A—ganglion—peripheral nervous system neoplasm	0.000909	0.0177	CbGeAlD
Chlorpromazine—CALM2—nerve—peripheral nervous system neoplasm	0.000905	0.0176	CbGeAlD
Chlorpromazine—CALM1—nerve—peripheral nervous system neoplasm	0.000901	0.0175	CbGeAlD
Chlorpromazine—CALM2—ganglion—peripheral nervous system neoplasm	0.000894	0.0173	CbGeAlD
Chlorpromazine—CALM1—ganglion—peripheral nervous system neoplasm	0.000889	0.0173	CbGeAlD
Chlorpromazine—HTR7—nerve—peripheral nervous system neoplasm	0.00088	0.0171	CbGeAlD
Chlorpromazine—HTR7—ganglion—peripheral nervous system neoplasm	0.000869	0.0169	CbGeAlD
Chlorpromazine—DRD2—nerve—peripheral nervous system neoplasm	0.000832	0.0162	CbGeAlD
Chlorpromazine—DRD2—ganglion—peripheral nervous system neoplasm	0.000821	0.0159	CbGeAlD
Chlorpromazine—DRD1—brainstem—peripheral nervous system neoplasm	0.000604	0.0117	CbGeAlD
Chlorpromazine—CALM3—trigeminal ganglion—peripheral nervous system neoplasm	0.000559	0.0109	CbGeAlD
Chlorpromazine—HTR2A—nerve—peripheral nervous system neoplasm	0.000549	0.0107	CbGeAlD
Chlorpromazine—HTR2A—ganglion—peripheral nervous system neoplasm	0.000542	0.0105	CbGeAlD
Chlorpromazine—CALM3—parotid gland—peripheral nervous system neoplasm	0.000527	0.0102	CbGeAlD
Chlorpromazine—SMPD1—cerebellum—peripheral nervous system neoplasm	0.000526	0.0102	CbGeAlD
Chlorpromazine—CHRM1—parotid gland—peripheral nervous system neoplasm	0.000473	0.00918	CbGeAlD
Chlorpromazine—HTR2C—brainstem—peripheral nervous system neoplasm	0.00047	0.00912	CbGeAlD
Chlorpromazine—Pancytopenia—Melphalan—peripheral nervous system neoplasm	0.000468	0.00505	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Alitretinoin—peripheral nervous system neoplasm	0.000464	0.005	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Tretinoin—peripheral nervous system neoplasm	0.000456	0.00492	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Isotretinoin—peripheral nervous system neoplasm	0.000456	0.00492	CcSEcCtD
Chlorpromazine—Drowsiness—Tretinoin—peripheral nervous system neoplasm	0.000445	0.0048	CcSEcCtD
Chlorpromazine—Drowsiness—Isotretinoin—peripheral nervous system neoplasm	0.000445	0.0048	CcSEcCtD
Chlorpromazine—CALM2—trigeminal ganglion—peripheral nervous system neoplasm	0.000439	0.00852	CbGeAlD
Chlorpromazine—CALM1—trigeminal ganglion—peripheral nervous system neoplasm	0.000437	0.00848	CbGeAlD
Chlorpromazine—Jaundice—Melphalan—peripheral nervous system neoplasm	0.000429	0.00462	CcSEcCtD
Chlorpromazine—Cardiac arrest—Alitretinoin—peripheral nervous system neoplasm	0.000417	0.00449	CcSEcCtD
Chlorpromazine—Agranulocytosis—Isotretinoin—peripheral nervous system neoplasm	0.000416	0.00448	CcSEcCtD
Chlorpromazine—Agranulocytosis—Tretinoin—peripheral nervous system neoplasm	0.000416	0.00448	CcSEcCtD
Chlorpromazine—CALM2—parotid gland—peripheral nervous system neoplasm	0.000414	0.00804	CbGeAlD
Chlorpromazine—Haemolytic anaemia—Cisplatin—peripheral nervous system neoplasm	0.000413	0.00446	CcSEcCtD
Chlorpromazine—Nasal congestion—Cisplatin—peripheral nervous system neoplasm	0.00041	0.00442	CcSEcCtD
Chlorpromazine—Dysphagia—Dactinomycin—peripheral nervous system neoplasm	0.000408	0.0044	CcSEcCtD
Chlorpromazine—Ethopropazine—BCHE—peripheral nervous system neoplasm	0.000406	0.216	CrCbGaD
Chlorpromazine—Cardiac arrest—Vincristine—peripheral nervous system neoplasm	0.000401	0.00433	CcSEcCtD
Chlorpromazine—Urinary retention—Vincristine—peripheral nervous system neoplasm	0.000401	0.00433	CcSEcCtD
Chlorpromazine—KCNH2—trigeminal ganglion—peripheral nervous system neoplasm	0.000398	0.00772	CbGeAlD
Chlorpromazine—HTR1A—brainstem—peripheral nervous system neoplasm	0.000395	0.00767	CbGeAlD
Chlorpromazine—Oedema peripheral—Tretinoin—peripheral nervous system neoplasm	0.000394	0.00425	CcSEcCtD
Chlorpromazine—Oedema peripheral—Isotretinoin—peripheral nervous system neoplasm	0.000394	0.00425	CcSEcCtD
Chlorpromazine—CALM2—brainstem—peripheral nervous system neoplasm	0.000388	0.00754	CbGeAlD
Chlorpromazine—Pancytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000388	0.00418	CcSEcCtD
Chlorpromazine—CALM1—brainstem—peripheral nervous system neoplasm	0.000387	0.00751	CbGeAlD
Chlorpromazine—Anaphylactoid reaction—Cisplatin—peripheral nervous system neoplasm	0.000386	0.00416	CcSEcCtD
Chlorpromazine—Visual impairment—Isotretinoin—peripheral nervous system neoplasm	0.000385	0.00415	CcSEcCtD
Chlorpromazine—Visual impairment—Tretinoin—peripheral nervous system neoplasm	0.000385	0.00415	CcSEcCtD
Chlorpromazine—Asthma—Alitretinoin—peripheral nervous system neoplasm	0.000379	0.00408	CcSEcCtD
Chlorpromazine—Dysphagia—Alitretinoin—peripheral nervous system neoplasm	0.000379	0.00408	CcSEcCtD
Chlorpromazine—HTR7—brainstem—peripheral nervous system neoplasm	0.000378	0.00733	CbGeAlD
Chlorpromazine—BCHE—trigeminal ganglion—peripheral nervous system neoplasm	0.000366	0.00711	CbGeAlD
Chlorpromazine—ADRA1A—brainstem—peripheral nervous system neoplasm	0.000364	0.00707	CbGeAlD
Chlorpromazine—DRD2—brainstem—peripheral nervous system neoplasm	0.000357	0.00693	CbGeAlD
Chlorpromazine—Anaphylactoid reaction—Etoposide—peripheral nervous system neoplasm	0.000353	0.00381	CcSEcCtD
Chlorpromazine—Pancytopenia—Vincristine—peripheral nervous system neoplasm	0.000346	0.00373	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Alitretinoin—peripheral nervous system neoplasm	0.000346	0.00373	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Cisplatin—peripheral nervous system neoplasm	0.000341	0.00367	CcSEcCtD
Chlorpromazine—Agranulocytosis—Dactinomycin—peripheral nervous system neoplasm	0.00034	0.00366	CcSEcCtD
Chlorpromazine—Nervousness—Isotretinoin—peripheral nervous system neoplasm	0.000338	0.00364	CcSEcCtD
Chlorpromazine—Nervousness—Tretinoin—peripheral nervous system neoplasm	0.000338	0.00364	CcSEcCtD
Chlorpromazine—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.000338	0.00364	CcSEcCtD
Chlorpromazine—Muscle spasms—Topotecan—peripheral nervous system neoplasm	0.000337	0.00364	CcSEcCtD
Chlorpromazine—Erectile dysfunction—Vincristine—peripheral nervous system neoplasm	0.000336	0.00362	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Vincristine—peripheral nervous system neoplasm	0.000333	0.00359	CcSEcCtD
Chlorpromazine—Triflupromazine—BCHE—peripheral nervous system neoplasm	0.000333	0.177	CrCbGaD
Chlorpromazine—Tremor—Tretinoin—peripheral nervous system neoplasm	0.000326	0.00352	CcSEcCtD
Chlorpromazine—Tremor—Isotretinoin—peripheral nervous system neoplasm	0.000326	0.00352	CcSEcCtD
Chlorpromazine—Glycosuria—Epirubicin—peripheral nervous system neoplasm	0.000326	0.00351	CcSEcCtD
Chlorpromazine—Cardiac arrest—Etoposide—peripheral nervous system neoplasm	0.000325	0.0035	CcSEcCtD
Chlorpromazine—BCHE—brainstem—peripheral nervous system neoplasm	0.000324	0.00629	CbGeAlD
Chlorpromazine—Angioedema—Topotecan—peripheral nervous system neoplasm	0.000321	0.00346	CcSEcCtD
Chlorpromazine—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.000319	0.00619	CbGeAlD
Chlorpromazine—Blood disorder—Epirubicin—peripheral nervous system neoplasm	0.000316	0.00341	CcSEcCtD
Chlorpromazine—Agranulocytosis—Alitretinoin—peripheral nervous system neoplasm	0.000315	0.0034	CcSEcCtD
Chlorpromazine—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.000314	0.00339	CcSEcCtD
Chlorpromazine—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000313	0.00608	CbGeAlD
Chlorpromazine—Syncope—Isotretinoin—peripheral nervous system neoplasm	0.000312	0.00336	CcSEcCtD
Chlorpromazine—Syncope—Tretinoin—peripheral nervous system neoplasm	0.000312	0.00336	CcSEcCtD
Chlorpromazine—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.000308	0.00332	CcSEcCtD
Chlorpromazine—Pancytopenia—Cisplatin—peripheral nervous system neoplasm	0.000306	0.0033	CcSEcCtD
Chlorpromazine—Cough—Topotecan—peripheral nervous system neoplasm	0.000306	0.0033	CcSEcCtD
Chlorpromazine—Loss of consciousness—Isotretinoin—peripheral nervous system neoplasm	0.000306	0.0033	CcSEcCtD
Chlorpromazine—Loss of consciousness—Tretinoin—peripheral nervous system neoplasm	0.000306	0.0033	CcSEcCtD
Chlorpromazine—Cough—Tretinoin—peripheral nervous system neoplasm	0.000304	0.00327	CcSEcCtD
Chlorpromazine—Cough—Isotretinoin—peripheral nervous system neoplasm	0.000304	0.00327	CcSEcCtD
Chlorpromazine—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.000302	0.00325	CcSEcCtD
Chlorpromazine—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.000302	0.00325	CcSEcCtD
Chlorpromazine—Glycosuria—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.00325	CcSEcCtD
Chlorpromazine—Amenorrhoea—Epirubicin—peripheral nervous system neoplasm	0.000301	0.00324	CcSEcCtD
Chlorpromazine—Jaundice cholestatic—Epirubicin—peripheral nervous system neoplasm	0.000301	0.00324	CcSEcCtD
Chlorpromazine—Cough—Melphalan—peripheral nervous system neoplasm	0.0003	0.00323	CcSEcCtD
Chlorpromazine—Oedema peripheral—Alitretinoin—peripheral nervous system neoplasm	0.000299	0.00322	CcSEcCtD
Chlorpromazine—Convulsion—Melphalan—peripheral nervous system neoplasm	0.000298	0.00321	CcSEcCtD
Chlorpromazine—Dysphagia—Etoposide—peripheral nervous system neoplasm	0.000296	0.00319	CcSEcCtD
Chlorpromazine—Blood disorder—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.00315	CcSEcCtD
Chlorpromazine—Visual impairment—Alitretinoin—peripheral nervous system neoplasm	0.000292	0.00315	CcSEcCtD
Chlorpromazine—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.00029	0.00312	CcSEcCtD
Chlorpromazine—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.00029	0.00312	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.000286	0.00309	CcSEcCtD
Chlorpromazine—Infection—Topotecan—peripheral nervous system neoplasm	0.000285	0.00307	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.000284	0.00306	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.000284	0.00306	CcSEcCtD
Chlorpromazine—Infection—Tretinoin—peripheral nervous system neoplasm	0.000282	0.00304	CcSEcCtD
Chlorpromazine—Infection—Isotretinoin—peripheral nervous system neoplasm	0.000282	0.00304	CcSEcCtD
Chlorpromazine—Dyskinesia—Epirubicin—peripheral nervous system neoplasm	0.000281	0.00303	CcSEcCtD
Chlorpromazine—Pancytopenia—Etoposide—peripheral nervous system neoplasm	0.000281	0.00303	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00028	0.00302	CcSEcCtD
Chlorpromazine—Shock—Tretinoin—peripheral nervous system neoplasm	0.00028	0.00301	CcSEcCtD
Chlorpromazine—Shock—Isotretinoin—peripheral nervous system neoplasm	0.00028	0.00301	CcSEcCtD
Chlorpromazine—Infection—Melphalan—peripheral nervous system neoplasm	0.000279	0.003	CcSEcCtD
Chlorpromazine—Amenorrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.003	CcSEcCtD
Chlorpromazine—Jaundice cholestatic—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.003	CcSEcCtD
Chlorpromazine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.000277	0.00299	CcSEcCtD
Chlorpromazine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.000277	0.00299	CcSEcCtD
Chlorpromazine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.000274	0.00295	CcSEcCtD
Chlorpromazine—Gait disturbance—Epirubicin—peripheral nervous system neoplasm	0.000271	0.00292	CcSEcCtD
Chlorpromazine—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.000265	0.00286	CcSEcCtD
Chlorpromazine—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.000265	0.00286	CcSEcCtD
Chlorpromazine—Hypotension—Melphalan—peripheral nervous system neoplasm	0.000262	0.00282	CcSEcCtD
Chlorpromazine—Dermatitis contact—Epirubicin—peripheral nervous system neoplasm	0.000261	0.00281	CcSEcCtD
Chlorpromazine—Dyskinesia—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.0028	CcSEcCtD
Chlorpromazine—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.000257	0.00277	CcSEcCtD
Chlorpromazine—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000257	0.00277	CcSEcCtD
Chlorpromazine—Jaundice—Etoposide—peripheral nervous system neoplasm	0.000257	0.00277	CcSEcCtD
Chlorpromazine—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.000256	0.00276	CcSEcCtD
Chlorpromazine—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.000255	0.00275	CcSEcCtD
Chlorpromazine—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.000255	0.00275	CcSEcCtD
Chlorpromazine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.000253	0.00273	CcSEcCtD
Chlorpromazine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.000253	0.00273	CcSEcCtD
Chlorpromazine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.000253	0.00272	CcSEcCtD
Chlorpromazine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.000253	0.00272	CcSEcCtD
Chlorpromazine—Gait disturbance—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.0027	CcSEcCtD
Chlorpromazine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00025	0.00269	CcSEcCtD
Chlorpromazine—Visual impairment—Cisplatin—peripheral nervous system neoplasm	0.000249	0.00268	CcSEcCtD
Chlorpromazine—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.000248	0.00267	CcSEcCtD
Chlorpromazine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.000247	0.00266	CcSEcCtD
Chlorpromazine—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.000246	0.00265	CcSEcCtD
Chlorpromazine—Constipation—Topotecan—peripheral nervous system neoplasm	0.000245	0.00264	CcSEcCtD
Chlorpromazine—CALM3—cerebellum—peripheral nervous system neoplasm	0.000244	0.00473	CbGeAlD
Chlorpromazine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000243	0.00262	CcSEcCtD
Chlorpromazine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000243	0.00262	CcSEcCtD
Chlorpromazine—Dermatitis contact—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.0026	CcSEcCtD
Chlorpromazine—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.000237	0.00255	CcSEcCtD
Chlorpromazine—HTR2A—brainstem—peripheral nervous system neoplasm	0.000236	0.00457	CbGeAlD
Chlorpromazine—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.000232	0.0025	CcSEcCtD
Chlorpromazine—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000231	0.00249	CcSEcCtD
Chlorpromazine—Cough—Alitretinoin—peripheral nervous system neoplasm	0.00023	0.00248	CcSEcCtD
Chlorpromazine—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.00247	CcSEcCtD
Chlorpromazine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000229	0.00246	CcSEcCtD
Chlorpromazine—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.000228	0.00245	CcSEcCtD
Chlorpromazine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000226	0.00244	CcSEcCtD
Chlorpromazine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000225	0.00242	CcSEcCtD
Chlorpromazine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000225	0.00242	CcSEcCtD
Chlorpromazine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00022	0.00237	CcSEcCtD
Chlorpromazine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00022	0.00237	CcSEcCtD
Chlorpromazine—Photosensitivity—Epirubicin—peripheral nervous system neoplasm	0.000218	0.00235	CcSEcCtD
Chlorpromazine—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000216	0.00233	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000215	0.00232	CcSEcCtD
Chlorpromazine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000215	0.00417	CbGeAlD
Chlorpromazine—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000214	0.00231	CcSEcCtD
Chlorpromazine—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000212	0.00228	CcSEcCtD
Chlorpromazine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000211	0.00227	CcSEcCtD
Chlorpromazine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000211	0.00227	CcSEcCtD
Chlorpromazine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00021	0.00227	CcSEcCtD
Chlorpromazine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000209	0.00226	CcSEcCtD
Chlorpromazine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000209	0.00226	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000207	0.00224	CcSEcCtD
Chlorpromazine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000207	0.00223	CcSEcCtD
Chlorpromazine—Infection—Vincristine—peripheral nervous system neoplasm	0.000206	0.00222	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Epirubicin—peripheral nervous system neoplasm	0.000203	0.00219	CcSEcCtD
Chlorpromazine—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.00218	CcSEcCtD
Chlorpromazine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000201	0.00217	CcSEcCtD
Chlorpromazine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000201	0.00217	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000198	0.00213	CcSEcCtD
Chlorpromazine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000198	0.00213	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000196	0.00212	CcSEcCtD
Chlorpromazine—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000195	0.00378	CbGeAlD
Chlorpromazine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000195	0.0021	CcSEcCtD
Chlorpromazine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000195	0.0021	CcSEcCtD
Chlorpromazine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000194	0.00209	CcSEcCtD
Chlorpromazine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000192	0.00207	CcSEcCtD
Chlorpromazine—CALM2—cerebellum—peripheral nervous system neoplasm	0.000191	0.00372	CbGeAlD
Chlorpromazine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000191	0.00206	CcSEcCtD
Chlorpromazine—CALM1—cerebellum—peripheral nervous system neoplasm	0.000191	0.0037	CbGeAlD
Chlorpromazine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000189	0.00204	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.00203	CcSEcCtD
Chlorpromazine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000188	0.00203	CcSEcCtD
Chlorpromazine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000188	0.00203	CcSEcCtD
Chlorpromazine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000188	0.00202	CcSEcCtD
Chlorpromazine—HTR7—cerebellum—peripheral nervous system neoplasm	0.000186	0.00362	CbGeAlD
Chlorpromazine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000184	0.00199	CcSEcCtD
Chlorpromazine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000184	0.00198	CcSEcCtD
Chlorpromazine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000184	0.00198	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000183	0.00198	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.00198	CcSEcCtD
Chlorpromazine—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000182	0.00196	CcSEcCtD
Chlorpromazine—Infection—Cisplatin—peripheral nervous system neoplasm	0.000182	0.00196	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.00196	CcSEcCtD
Chlorpromazine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000181	0.00195	CcSEcCtD
Chlorpromazine—Cough—Etoposide—peripheral nervous system neoplasm	0.00018	0.00194	CcSEcCtD
Chlorpromazine—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.00018	0.00349	CbGeAlD
Chlorpromazine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000179	0.00193	CcSEcCtD
Chlorpromazine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000178	0.00192	CcSEcCtD
Chlorpromazine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000177	0.00191	CcSEcCtD
Chlorpromazine—DRD2—cerebellum—peripheral nervous system neoplasm	0.000176	0.00342	CbGeAlD
Chlorpromazine—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000175	0.00189	CcSEcCtD
Chlorpromazine—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000174	0.00339	CbGeAlD
Chlorpromazine—KCNH2—cerebellum—peripheral nervous system neoplasm	0.000173	0.00337	CbGeAlD
Chlorpromazine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000171	0.00185	CcSEcCtD
Chlorpromazine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000171	0.00184	CcSEcCtD
Chlorpromazine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00017	0.00183	CcSEcCtD
Chlorpromazine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.00182	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000168	0.00181	CcSEcCtD
Chlorpromazine—Infection—Etoposide—peripheral nervous system neoplasm	0.000167	0.0018	CcSEcCtD
Chlorpromazine—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000166	0.00179	CcSEcCtD
Chlorpromazine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000166	0.00179	CcSEcCtD
Chlorpromazine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000166	0.00179	CcSEcCtD
Chlorpromazine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000164	0.00177	CcSEcCtD
Chlorpromazine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000164	0.00177	CcSEcCtD
Chlorpromazine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000164	0.00177	CcSEcCtD
Chlorpromazine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000164	0.00176	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.00175	CcSEcCtD
Chlorpromazine—BCHE—cerebellum—peripheral nervous system neoplasm	0.00016	0.0031	CbGeAlD
Chlorpromazine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000159	0.00171	CcSEcCtD
Chlorpromazine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000157	0.0017	CcSEcCtD
Chlorpromazine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000157	0.00169	CcSEcCtD
Chlorpromazine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.00165	CcSEcCtD
Chlorpromazine—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.00165	CcSEcCtD
Chlorpromazine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.00165	CcSEcCtD
Chlorpromazine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000153	0.00165	CcSEcCtD
Chlorpromazine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.00164	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000151	0.00163	CcSEcCtD
Chlorpromazine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00015	0.00162	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000149	0.00161	CcSEcCtD
Chlorpromazine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000149	0.00161	CcSEcCtD
Chlorpromazine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000148	0.00159	CcSEcCtD
Chlorpromazine—Diltiazem—ABCB1—peripheral nervous system neoplasm	0.000146	0.0777	CrCbGaD
Chlorpromazine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.00157	CcSEcCtD
Chlorpromazine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000145	0.00156	CcSEcCtD
Chlorpromazine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000144	0.00155	CcSEcCtD
Chlorpromazine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000144	0.00155	CcSEcCtD
Chlorpromazine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000142	0.00153	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.00151	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.00149	CcSEcCtD
Chlorpromazine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000138	0.00149	CcSEcCtD
Chlorpromazine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000137	0.00148	CcSEcCtD
Chlorpromazine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.00147	CcSEcCtD
Chlorpromazine—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.000137	0.00265	CbGeAlD
Chlorpromazine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000135	0.00146	CcSEcCtD
Chlorpromazine—CYP2E1—cerebellum—peripheral nervous system neoplasm	0.000134	0.00259	CbGeAlD
Chlorpromazine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.00144	CcSEcCtD
Chlorpromazine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000133	0.00143	CcSEcCtD
Chlorpromazine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000131	0.00141	CcSEcCtD
Chlorpromazine—Triflupromazine—ABCB1—peripheral nervous system neoplasm	0.00013	0.0693	CrCbGaD
Chlorpromazine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000128	0.00138	CcSEcCtD
Chlorpromazine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.00137	CcSEcCtD
Chlorpromazine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000124	0.00133	CcSEcCtD
Chlorpromazine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.0013	CcSEcCtD
Chlorpromazine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.00127	CcSEcCtD
Chlorpromazine—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000116	0.00225	CbGeAlD
Chlorpromazine—Clobazam—ABCB1—peripheral nervous system neoplasm	0.000116	0.0616	CrCbGaD
Chlorpromazine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000112	0.00121	CcSEcCtD
Chlorpromazine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000111	0.0012	CcSEcCtD
Chlorpromazine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000111	0.0012	CcSEcCtD
Chlorpromazine—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000106	0.00205	CbGeAlD
Chlorpromazine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.00112	CcSEcCtD
Chlorpromazine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000104	0.00112	CcSEcCtD
Chlorpromazine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000103	0.00111	CcSEcCtD
Chlorpromazine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.00111	CcSEcCtD
Chlorpromazine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000101	0.00109	CcSEcCtD
Chlorpromazine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000101	0.00109	CcSEcCtD
Chlorpromazine—Fluphenazine—ABCB1—peripheral nervous system neoplasm	0.0001	0.0533	CrCbGaD
Chlorpromazine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.0001	0.00108	CcSEcCtD
Chlorpromazine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	9.61e-05	0.00104	CcSEcCtD
Chlorpromazine—Syncope—Doxorubicin—peripheral nervous system neoplasm	9.58e-05	0.00103	CcSEcCtD
Chlorpromazine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	9.56e-05	0.00103	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	9.42e-05	0.00102	CcSEcCtD
Chlorpromazine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	9.39e-05	0.00101	CcSEcCtD
Chlorpromazine—Infection—Epirubicin—peripheral nervous system neoplasm	9.36e-05	0.00101	CcSEcCtD
Chlorpromazine—Cough—Doxorubicin—peripheral nervous system neoplasm	9.32e-05	0.001	CcSEcCtD
Chlorpromazine—Shock—Epirubicin—peripheral nervous system neoplasm	9.27e-05	0.000999	CcSEcCtD
Chlorpromazine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	9.25e-05	0.000998	CcSEcCtD
Chlorpromazine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	9.19e-05	0.000991	CcSEcCtD
Chlorpromazine—Clomipramine—ABCB1—peripheral nervous system neoplasm	9.17e-05	0.0487	CrCbGaD
Chlorpromazine—Chlorprothixene—ABCB1—peripheral nervous system neoplasm	9.13e-05	0.0485	CrCbGaD
Chlorpromazine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	8.89e-05	0.000959	CcSEcCtD
Chlorpromazine—Hypotension—Epirubicin—peripheral nervous system neoplasm	8.8e-05	0.000949	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	8.72e-05	0.00094	CcSEcCtD
Chlorpromazine—Infection—Doxorubicin—peripheral nervous system neoplasm	8.66e-05	0.000933	CcSEcCtD
Chlorpromazine—Shock—Doxorubicin—peripheral nervous system neoplasm	8.58e-05	0.000924	CcSEcCtD
Chlorpromazine—Flurazepam—ABCB1—peripheral nervous system neoplasm	8.52e-05	0.0453	CrCbGaD
Chlorpromazine—Insomnia—Epirubicin—peripheral nervous system neoplasm	8.52e-05	0.000918	CcSEcCtD
Chlorpromazine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	8.51e-05	0.000917	CcSEcCtD
Chlorpromazine—Trimipramine—ABCB1—peripheral nervous system neoplasm	8.43e-05	0.0448	CrCbGaD
Chlorpromazine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	8.4e-05	0.000905	CcSEcCtD
Chlorpromazine—Somnolence—Epirubicin—peripheral nervous system neoplasm	8.38e-05	0.000903	CcSEcCtD
Chlorpromazine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	8.15e-05	0.000878	CcSEcCtD
Chlorpromazine—Promethazine—ABCB1—peripheral nervous system neoplasm	8.12e-05	0.0432	CrCbGaD
Chlorpromazine—Constipation—Epirubicin—peripheral nervous system neoplasm	8.06e-05	0.000868	CcSEcCtD
Chlorpromazine—Trifluoperazine—ABCB1—peripheral nervous system neoplasm	8.01e-05	0.0426	CrCbGaD
Chlorpromazine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	7.88e-05	0.00085	CcSEcCtD
Chlorpromazine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	7.77e-05	0.000838	CcSEcCtD
Chlorpromazine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	7.75e-05	0.000835	CcSEcCtD
Chlorpromazine—ABCB1—cerebellum—peripheral nervous system neoplasm	7.61e-05	0.00148	CbGeAlD
Chlorpromazine—Constipation—Doxorubicin—peripheral nervous system neoplasm	7.45e-05	0.000804	CcSEcCtD
Chlorpromazine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	7.45e-05	0.000803	CcSEcCtD
Chlorpromazine—Desipramine—ABCB1—peripheral nervous system neoplasm	7.38e-05	0.0392	CrCbGaD
Chlorpromazine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	6.94e-05	0.000748	CcSEcCtD
Chlorpromazine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	6.89e-05	0.000743	CcSEcCtD
Chlorpromazine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	6.42e-05	0.000692	CcSEcCtD
Chlorpromazine—Imipramine—ABCB1—peripheral nervous system neoplasm	6.26e-05	0.0332	CrCbGaD
Chlorpromazine—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.23e-05	0.000672	CcSEcCtD
Chlorpromazine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	5.76e-05	0.000621	CcSEcCtD
Chlorpromazine—CALM1—Immune System—ERBB2—peripheral nervous system neoplasm	5.35e-06	6.2e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.34e-06	6.18e-05	CbGpPWpGaD
Chlorpromazine—DRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.32e-06	6.15e-05	CbGpPWpGaD
Chlorpromazine—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	5.31e-06	6.15e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Innate Immune System—HRAS—peripheral nervous system neoplasm	5.29e-06	6.12e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.27e-06	6.1e-05	CbGpPWpGaD
Chlorpromazine—DRD3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.25e-06	6.07e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.2e-06	6.01e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Hemostasis—AKT1—peripheral nervous system neoplasm	5.19e-06	6e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.13e-06	5.94e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.12e-06	5.93e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.12e-06	5.92e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Innate Immune System—HRAS—peripheral nervous system neoplasm	5.12e-06	5.92e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Innate Immune System—HRAS—peripheral nervous system neoplasm	5.12e-06	5.92e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—ERBB2—peripheral nervous system neoplasm	5.11e-06	5.91e-05	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.08e-06	5.88e-05	CbGpPWpGaD
Chlorpromazine—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	5.08e-06	5.88e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	5.08e-06	5.88e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.05e-06	5.85e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Hemostasis—AKT1—peripheral nervous system neoplasm	5.02e-06	5.81e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Hemostasis—AKT1—peripheral nervous system neoplasm	5.02e-06	5.81e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.99e-06	5.77e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.97e-06	5.75e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.96e-06	5.74e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—ERBB2—peripheral nervous system neoplasm	4.94e-06	5.72e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—ERBB2—peripheral nervous system neoplasm	4.94e-06	5.72e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	4.91e-06	5.69e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	4.91e-06	5.69e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.9e-06	5.68e-05	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.86e-06	5.63e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.83e-06	5.59e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.78e-06	5.53e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.77e-06	5.52e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.76e-06	5.51e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.75e-06	5.5e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	4.74e-06	5.49e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	4.71e-06	5.46e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.7e-06	5.44e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.68e-06	5.42e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.68e-06	5.41e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Innate Immune System—AKT1—peripheral nervous system neoplasm	4.67e-06	5.4e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.63e-06	5.35e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.61e-06	5.33e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.57e-06	5.29e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.57e-06	5.29e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.55e-06	5.26e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.53e-06	5.24e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.53e-06	5.24e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.52e-06	5.23e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Innate Immune System—AKT1—peripheral nervous system neoplasm	4.52e-06	5.23e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Innate Immune System—AKT1—peripheral nervous system neoplasm	4.52e-06	5.23e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.51e-06	5.21e-05	CbGpPWpGaD
Chlorpromazine—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	4.49e-06	5.19e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	4.49e-06	5.19e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.48e-06	5.18e-05	CbGpPWpGaD
Chlorpromazine—ABCB11—Metabolism—AKT1—peripheral nervous system neoplasm	4.46e-06	5.16e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.46e-06	5.16e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.46e-06	5.16e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	4.46e-06	5.16e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.42e-06	5.11e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.38e-06	5.07e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.38e-06	5.07e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.38e-06	5.07e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.36e-06	5.05e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.36e-06	5.04e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.35e-06	5.04e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	4.34e-06	5.02e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	4.34e-06	5.02e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.31e-06	4.99e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.31e-06	4.99e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.3e-06	4.98e-05	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.29e-06	4.97e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.29e-06	4.96e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.27e-06	4.95e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.23e-06	4.9e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.22e-06	4.89e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—NRAS—peripheral nervous system neoplasm	4.21e-06	4.87e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.15e-06	4.8e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.13e-06	4.78e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.13e-06	4.78e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.11e-06	4.76e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—NRAS—peripheral nervous system neoplasm	4.07e-06	4.71e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—NRAS—peripheral nervous system neoplasm	4.07e-06	4.71e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.06e-06	4.7e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.06e-06	4.7e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.05e-06	4.69e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.04e-06	4.68e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.03e-06	4.66e-05	CbGpPWpGaD
Chlorpromazine—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.01e-06	4.65e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.99e-06	4.62e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.98e-06	4.6e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.98e-06	4.6e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.95e-06	4.58e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.95e-06	4.57e-05	CbGpPWpGaD
Chlorpromazine—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.94e-06	4.56e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.93e-06	4.55e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.92e-06	4.54e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.92e-06	4.54e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.92e-06	4.54e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.92e-06	4.53e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.91e-06	4.53e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.91e-06	4.52e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.89e-06	4.5e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—NRAS—peripheral nervous system neoplasm	3.89e-06	4.5e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.88e-06	4.49e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.88e-06	4.49e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.87e-06	4.48e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.84e-06	4.45e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.83e-06	4.43e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.8e-06	4.39e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.78e-06	4.37e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—NRAS—peripheral nervous system neoplasm	3.76e-06	4.35e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—NRAS—peripheral nervous system neoplasm	3.76e-06	4.35e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.75e-06	4.34e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.75e-06	4.34e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.75e-06	4.34e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.7e-06	4.28e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.65e-06	4.22e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3.64e-06	4.21e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—MYC—peripheral nervous system neoplasm	3.62e-06	4.19e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.62e-06	4.18e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.59e-06	4.16e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.59e-06	4.15e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.59e-06	4.15e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.58e-06	4.14e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.58e-06	4.14e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.58e-06	4.14e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	3.57e-06	4.13e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.57e-06	4.13e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.56e-06	4.12e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.56e-06	4.12e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.54e-06	4.09e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.52e-06	4.08e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.52e-06	4.07e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.51e-06	4.06e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—MYC—peripheral nervous system neoplasm	3.5e-06	4.05e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—MYC—peripheral nervous system neoplasm	3.5e-06	4.05e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.46e-06	4.01e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.46e-06	4.01e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.43e-06	3.96e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.38e-06	3.91e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.37e-06	3.9e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.37e-06	3.9e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.33e-06	3.86e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.33e-06	3.86e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.31e-06	3.83e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.31e-06	3.83e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.28e-06	3.8e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.27e-06	3.79e-05	CbGpPWpGaD
Chlorpromazine—BCHE—Metabolism—AKT1—peripheral nervous system neoplasm	3.27e-06	3.78e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.26e-06	3.78e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.26e-06	3.78e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.26e-06	3.77e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.26e-06	3.77e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.25e-06	3.76e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.25e-06	3.76e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.23e-06	3.74e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.22e-06	3.73e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.21e-06	3.72e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.19e-06	3.69e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.17e-06	3.67e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.14e-06	3.64e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.14e-06	3.64e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.11e-06	3.59e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—HRAS—peripheral nervous system neoplasm	3.08e-06	3.57e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.06e-06	3.54e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.05e-06	3.53e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.04e-06	3.52e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.03e-06	3.51e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.02e-06	3.5e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	3e-06	3.47e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.99e-06	3.46e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.98e-06	3.45e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—HRAS—peripheral nervous system neoplasm	2.98e-06	3.45e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—HRAS—peripheral nervous system neoplasm	2.98e-06	3.45e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.98e-06	3.45e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.9e-06	3.36e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.89e-06	3.34e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.88e-06	3.33e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.88e-06	3.33e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.85e-06	3.3e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—HRAS—peripheral nervous system neoplasm	2.84e-06	3.29e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.81e-06	3.26e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.78e-06	3.22e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.78e-06	3.21e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.77e-06	3.2e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.76e-06	3.2e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—HRAS—peripheral nervous system neoplasm	2.75e-06	3.18e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—HRAS—peripheral nervous system neoplasm	2.75e-06	3.18e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.72e-06	3.15e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—AKT1—peripheral nervous system neoplasm	2.72e-06	3.15e-05	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.72e-06	3.15e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.65e-06	3.06e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.63e-06	3.05e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.63e-06	3.05e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—AKT1—peripheral nervous system neoplasm	2.63e-06	3.05e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—AKT1—peripheral nervous system neoplasm	2.63e-06	3.05e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.55e-06	2.95e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.54e-06	2.93e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—AKT1—peripheral nervous system neoplasm	2.51e-06	2.91e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—AKT1—peripheral nervous system neoplasm	2.51e-06	2.91e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.51e-06	2.9e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.5e-06	2.9e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.5e-06	2.89e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.49e-06	2.88e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.46e-06	2.85e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.46e-06	2.84e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.45e-06	2.84e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.45e-06	2.84e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.45e-06	2.84e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.44e-06	2.82e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.44e-06	2.82e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—AKT1—peripheral nervous system neoplasm	2.43e-06	2.81e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—AKT1—peripheral nervous system neoplasm	2.43e-06	2.81e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.4e-06	2.78e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.39e-06	2.77e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.39e-06	2.76e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.38e-06	2.75e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.36e-06	2.73e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.35e-06	2.72e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.34e-06	2.7e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	2.31e-06	2.67e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.28e-06	2.64e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.18e-06	2.53e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.15e-06	2.49e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.12e-06	2.45e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	2.12e-06	2.45e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.11e-06	2.45e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.11e-06	2.44e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—AKT1—peripheral nervous system neoplasm	2.1e-06	2.43e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.1e-06	2.43e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.08e-06	2.41e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.08e-06	2.41e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.07e-06	2.4e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—AKT1—peripheral nervous system neoplasm	2.03e-06	2.35e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—AKT1—peripheral nervous system neoplasm	2.03e-06	2.35e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.01e-06	2.33e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.01e-06	2.33e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.99e-06	2.31e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.93e-06	2.23e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.93e-06	2.23e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.93e-06	2.23e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	1.82e-06	2.11e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.76e-06	2.04e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.7e-06	1.97e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.7e-06	1.97e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.59e-06	1.84e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.5e-06	1.74e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.27e-06	1.47e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	9.82e-07	1.14e-05	CbGpPWpGaD
